161 related articles for article (PubMed ID: 26320772)
41. Functional SNP in stem of mir-146a affects Her2 status and breast cancer survival.
Meshkat M; Tanha HM; Naeini MM; Ghaedi K; Sanati MH; Meshkat M; Bagheri F
Cancer Biomark; 2016 Jul; 17(2):213-22. PubMed ID: 27434289
[TBL] [Abstract][Full Text] [Related]
42. Int7G24A variant of transforming growth factor-beta receptor type I is associated with invasive breast cancer.
Chen T; Jackson CR; Link A; Markey MP; Colligan BM; Douglass LE; Pemberton JO; Deddens JA; Graff JR; Carter JH
Clin Cancer Res; 2006 Jan; 12(2):392-7. PubMed ID: 16428477
[TBL] [Abstract][Full Text] [Related]
43. The APOBEC3B deletion polymorphism is associated with prevalence of hepatitis B virus, hepatitis C virus, Torque Teno virus, and Toxoplasma gondii co-infection among HIV-infected individuals.
Prasetyo AA; Sariyatun R; Reviono ; Sari Y; Hudiyono ; Haryati S; Adnan ZA; Hartono ; Kageyama S
J Clin Virol; 2015 Sep; 70():67-71. PubMed ID: 26305823
[TBL] [Abstract][Full Text] [Related]
44. A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3'UTR enhances chromosomal DNA damage.
Caval V; Suspène R; Shapira M; Vartanian JP; Wain-Hobson S
Nat Commun; 2014 Oct; 5():5129. PubMed ID: 25298230
[TBL] [Abstract][Full Text] [Related]
45. Integrative functional genomics identifies regulatory genetic variant modulating RAB31 expression and altering susceptibility to breast cancer.
Zhang Y; Yang B; Cheng X; Liu L; Zhu Y; Gong Y; Yang Y; Tian J; Peng X; Zou D; Yang L; Mei S; Wang X; Lou J; Ke J; Li J; Gong J; Chang J; Yuan P; Zhong R
Mol Carcinog; 2018 Dec; 57(12):1845-1854. PubMed ID: 30182384
[TBL] [Abstract][Full Text] [Related]
46. APOBEC3A catalyzes mutation and drives carcinogenesis in vivo.
Law EK; Levin-Klein R; Jarvis MC; Kim H; Argyris PP; Carpenter MA; Starrett GJ; Temiz NA; Larson LK; Durfee C; Burns MB; Vogel RI; Stavrou S; Aguilera AN; Wagner S; Largaespada DA; Starr TK; Ross SR; Harris RS
J Exp Med; 2020 Dec; 217(12):. PubMed ID: 32870257
[TBL] [Abstract][Full Text] [Related]
47. Single nucleotide polymorphisms in chromosomal instability genes and risk and clinical outcome of breast cancer: a Swedish prospective case-control study.
Brendle A; Brandt A; Johansson R; Enquist K; Hallmans G; Hemminki K; Lenner P; Försti A
Eur J Cancer; 2009 Feb; 45(3):435-42. PubMed ID: 19008095
[TBL] [Abstract][Full Text] [Related]
48. Association of type 2 diabetes genetic variants with breast cancer survival among Chinese women.
Bao PP; Zhao ZG; Gao YT; Zheng Y; Zhang B; Cai H; Zheng W; Shu XO; Lu W
PLoS One; 2015; 10(2):e0117419. PubMed ID: 25679392
[TBL] [Abstract][Full Text] [Related]
49. APOBEC3A/B-induced mutagenesis is responsible for 20% of heritable mutations in the TpCpW context.
Seplyarskiy VB; Andrianova MA; Bazykin GA
Genome Res; 2017 Feb; 27(2):175-184. PubMed ID: 27940951
[TBL] [Abstract][Full Text] [Related]
50. A germ-line deletion of APOBEC3B does not contribute to subtype-specific childhood acute lymphoblastic leukemia etiology.
Wallace AD; Francis SS; Shao X; de Smith AJ; Walsh KM; Mckean-Cowdin R; Ma X; Dahl G; Barcellos LF; Wiemels JL; Metayer C
Haematologica; 2018 Jan; 103(1):e29-e31. PubMed ID: 29025908
[No Abstract] [Full Text] [Related]
51. Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif.
Land AM; Wang J; Law EK; Aberle R; Kirmaier A; Krupp A; Johnson WE; Harris RS
Oncotarget; 2015 Nov; 6(37):39969-79. PubMed ID: 26544511
[TBL] [Abstract][Full Text] [Related]
52. Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria.
Wang S; Pitt JJ; Zheng Y; Yoshimatsu TF; Gao G; Sanni A; Oluwasola O; Ajani M; Fitzgerald D; Odetunde A; Khramtsova G; Hurley I; Popoola A; Falusi A; Ogundiran T; Obafunwa J; Ojengbede O; Ibrahim N; Barretina J; White KP; Huo D; Olopade OI
Int J Cancer; 2019 Dec; 145(12):3321-3333. PubMed ID: 31173346
[TBL] [Abstract][Full Text] [Related]
53. Association of PALB2 sequence variants with the risk of familial and early-onset breast cancer in a South-American population.
Leyton Y; Gonzalez-Hormazabal P; Blanco R; Bravo T; Fernandez-Ramires R; Morales S; Landeros N; Reyes JM; Peralta O; Tapia JC; Gomez F; Waugh E; Ibañez G; Pakomio J; Grau G; Jara L
BMC Cancer; 2015 Jan; 15():30. PubMed ID: 25636233
[TBL] [Abstract][Full Text] [Related]
54. Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer.
Huang X; Yang Y; Guo Y; Cao ZL; Cui ZW; Hu TC; Gao LB
Genet Mol Res; 2015 Dec; 14(4):16913-20. PubMed ID: 26681038
[TBL] [Abstract][Full Text] [Related]
55. Molecular mechanism and clinical impact of APOBEC3B-catalyzed mutagenesis in breast cancer.
Harris RS
Breast Cancer Res; 2015 Jan; 17(1):8. PubMed ID: 25848704
[TBL] [Abstract][Full Text] [Related]
56. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
57. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
Anticancer Res; 2015 Nov; 35(11):5901-4. PubMed ID: 26504013
[TBL] [Abstract][Full Text] [Related]
58. Germline APOBEC3B deletion increases somatic hypermutation in Asian breast cancer that is associated with Her2 subtype, PIK3CA mutations and immune activation.
Pan JW; Zabidi MMA; Chong BK; Meng MY; Ng PS; Hasan SN; Sandey B; Bahnu S; Rajadurai P; Yip CH; Rueda OM; Caldas C; Chin SF; Teo SH
Int J Cancer; 2021 May; 148(10):2489-2501. PubMed ID: 33423300
[TBL] [Abstract][Full Text] [Related]
59. Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant.
de Bock GH; Schutte M; Krol-Warmerdam EM; Seynaeve C; Blom J; Brekelmans CT; Meijers-Heijboer H; van Asperen CJ; Cornelisse CJ; Devilee P; Tollenaar RA; Klijn JG
J Med Genet; 2004 Oct; 41(10):731-5. PubMed ID: 15466005
[TBL] [Abstract][Full Text] [Related]
60. Association study of hsa-mir-603 rs11014002 polymorphism and risk of breast cancer in a sample of Iranian population.
Hashemi M; Sanaei S; Mashhadi MA; Hashemi SM; Taheri M; Ghavami S
Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):69-73. PubMed ID: 26718432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
